John E. Gallagher III serves as the Senior Vice President and Chief Financial Officer at Certara, Inc., a leading provider of model-informed drug development, regulatory science, and market access solutions. In his role, Gallagher is responsible for overseeing the company's financial operations, including financial planning and analysis, accounting, tax, treasury, and investor relations. His strategic vision and financial acumen have been instrumental in guiding Certara through its growth and expansion, particularly following its successful initial public offering in 2020. Gallagher brings a wealth of experience to Certara, having held senior financial leadership positions at several prominent companies. Prior to joining Certara in 2017, he served as the CFO of Acceleron Pharma, where he played a key role in the company's growth and eventual acquisition by Merck & Co. Earlier in his career, Gallagher held various finance roles at Biogen, culminating in his position as Vice President of Finance. His extensive experience in the life sciences industry, coupled with his strong financial expertise, has enabled him to effectively navigate the complex challenges faced by Certara as it continues to expand its global presence and service offerings. Under Gallagher's leadership, Certara has achieved significant milestones, including the successful integration of several strategic acquisitions and the expansion of its software and services portfolio. His focus on driving operational efficiency and fostering a culture of financial discipline has positioned Certara for long-term success in the rapidly evolving field of model-informed drug development. As Certara continues to innovate and deliver value to its clients, Gallagher's strategic guidance and financial stewardship will remain crucial to the company's ongoing growth and success.